Los Angeles Capital Management LLC Rhythm Pharmaceuticals, Inc. Transaction History

Los Angeles Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$21.39 - $49.64 $60,490 - $140,381	-2,828 Reduced 21.07%	10,593 $486,000
Q3 2023 Nov 06, 2023	BUY	$15.81 - $27.8 $212,186 - $373,103	13,421 New	13,421 $307,000
Q1 2021 May 05, 2021	SELL	$20.25 - $39.49 $245,612 - $478,974	-12,129 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$21.17 - $32.61 $5,292 - $8,152	-250 Reduced 2.02%	12,129 $361,000
Q3 2020 Nov 02, 2020	BUY	$18.13 - $30.61 $224,431 - $378,921	12,379 New	12,379 $268,000

178

69.1M

467K

224K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.86B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.